Skip to main content

Table 1 RNA-seq and ATAC-seq patient profile

From: Chromatin accessibility analysis identifies GSTM1 as a prognostic marker in human glioblastoma patients

Patient profile

Tissue ID

Overall survival (days)

Onset age

Sex

ATAC-seq

RNA-seq

Short-survival (chemoresistant; CR)

(< 0.5 years)

Short-Survival-1

145

58

M

v

v

Short-Survival-2

147

72

F

v

v

Short-Survival-3

173

58

M

-

v

Short-Survival-4

183

68

F

v

v

Short-Survival-5

112

41

M

v

–

Long-survival (chemosensitive; CS)

(> 2 years)

Long-survival-1

1500

58

M

v

v

Long-survival-2

2633

57

M

-

v

Long-survival-3

1037

61

M

v

v

Long-survival-4

1461

54

M

v

v

Long-survival-5

1597

54

F

v

–

Normal

Normal-1

 

63

F

v

v

Normal-2

 

54

M

v

v

Normal-3

 

53

M

v

–

Normal-4

 

65

M

v

–